輸入代號或公司名稱後按 Enter
4174

浩鼎

-0.70 (-2.68%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
25.45205成交張數本益比2.25股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-1.50-16.03-1.98-1292.9%-13.38%-73.93%
2026Q1-3.35-17.01-4.40-7916.8%-26.27%-83.06%
2025Q4-9.40-15.61-4.19-2013.1%-20.59%-71.99%
2025Q3-1.78-9.20-4.68-4450.9%-19.41%-103.86%
2025Q2-2.48-9.71-6.53-5122.3%-21.98%-87.54%
2025Q1-1.95-9.58-5.12-3538.1%-14.37%-69.64%
2024Q4-2.99-9.89-7.28-6302.6%-23.57%-60.62%
2024Q3-2.29-9.17-5.19-2259.8%-19.85%-63.00%
2024Q2-2.34-231.8%-9.34-5.41-2843.2%-17.53%-55.68%
2024Q1-2.26-5.22-5.22-5717.1%-14.70%-31.19%
2023Q4-2.27-4.54-5.24-2846.8%-12.89%-24.80%
2023Q3-2.46-4.80-5.68-4948.1%-12.35%-23.18%
2023Q21.78-4.024.094144.6%8.79%-18.11%
2023Q1-1.58-7.29-3.63-20339.5%-8.02%-33.30%
2022Q4-2.53-7.22-5.78-113953.6%-11.80%-43.93%
2022Q3-1.69-7.53-3.88-36049.6%-7.42%-37.91%
2022Q2-1.49-7.45-3.43-18365.6%-6.30%-34.59%
2022Q1-1.51-8.01-3.06-24232.3%-7.34%-33.29%
2021Q4-2.84-7.63-5.59-22259.8%-18.72%-44.08%
2021Q3-1.61-6.73-3.25-11660.9%-9.52%-36.19%
2021Q2-2.05-7.10-4.16-4611.8%-10.93%-34.54%
2021Q1-1.14-6.69-2.31-5186.0%-5.60%-29.29%
2020Q4-1.94-7.19-3.69-462.1%-8.80%-29.53%
2020Q3-1.98-7.95-3.80-68675.1%-8.77%-31.18%
2020Q2-1.64-7.64-3.15-522.6%-6.75%-27.99%
2020Q1-1.64-8.04-3.14-112502.2%-6.33%-33.55%
2019Q4-2.70-7.60-5.10-167361.0%-9.55%-29.77%
2019Q3-1.68-7.17-3.21-147892.2%-5.58%-25.28%
2019Q2-2.03-7.82-3.62-266512.5%-7.18%-25.40%
2019Q1-1.21-6.57-2.13-99622.4%-5.00%-25.16%
2018Q4-2.26-6.84-4.04-145868.2%-8.93%-25.98%
2018Q3-2.32-6.61-4.15-131803.5%-8.50%-23.42%
2018Q2-0.78-6.19-1.40-35555.7%-2.75%-20.57%
2018Q1-1.47-6.98-2.63-2125.7%-5.15%-22.64%
2017Q4-2.02-7.81-3.59-3586580.0%-6.89%-24.59%
2017Q3-1.91-7.35-3.37-6.14%-22.22%
2017Q2-1.58-7.54-2.80-76488.5%-4.91%-21.78%
2017Q1-2.30-6.63-4.04-6.76%-18.86%
2016Q4-1.57-6.31-2.78-770922.2%-4.44%
2016Q3-2.09-3.67-5.68%